Distinct Functions of Senescence-Associated Immune Responses in Liver Tumor Surveillance and Tumor Progression

Cancer Cell

Volumn 30, Issue 4, 2016, Pages 533-547

  Eggert, Tobias ^a   Wolter, Katharina ^b   Ji, Juling ^a   Ma, Chi ^a   Yevsa, Tetyana ^b   Klotz, Sabrina ^b   Medina Echeverz, José ^a   Longerich, Thomas ^c   Forgues, Marshonna ^a   Reisinger, Florian ^d,e   Heikenwalder, Mathias ^d,e   Wang, Xin Wei ^a   Zender, Lars ^b,e   Greten, Tim F ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

CCL2; CCR2; HCC; hepatocellular carcinoma; liver cancer; macrophages; MDSC; myeloid cells; NK cells; senescence

Indexed keywords

CD11B ANTIGEN; CD68 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR2; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCYTE CHEMOTACTIC PROTEIN 1; PROSTAGLANDIN SYNTHASE; PROTEIN P16; PROTEIN P21; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CANCER GROWTH; CANCER PROGNOSIS; CELL AGING; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IMMUNE RESPONSE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; MONOCYTE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; DISEASE COURSE; HUMAN; IMMUNOLOGY; IMMUNOSURVEILLANCE; KNOCKOUT MOUSE; LIVER TUMOR; PATHOLOGY;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL AGING; DISEASE PROGRESSION; FEMALE; HUMANS; IMMUNOLOGIC SURVEILLANCE; LIVER NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 84991745932     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccell.2016.09.003     Document Type: Article

References (40)

1. Acosta, J.C., Gil, J., Senescence: a new weapon for cancer therapy. Trends Cell Biol. 22 (2012), 211–219.
2. Acosta, J.C., O'Loghlen, A., Banito, A., Guijarro, M.V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell 133 (2008), 1006–1018.
3. Acosta, J.C., Banito, A., Wuestefeld, T., Georgilis, A., Janich, P., Morton, J.P., Athineos, D., Kang, T.W., Lasitschka, F., Andrulis, M., et al. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat. Cell Biol. 15 (2013), 978–990.
4. Cai, L., Zhang, Z., Zhou, L., Wang, H., Fu, J., Zhang, S., Shi, M., Zhang, H., Yang, Y., Wu, H., et al. Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Clin. Immunol. 129 (2008), 428–437.
5. Conti, I., Rollins, B.J., CCL2 (monocyte chemoattractant protein-1) and cancer. Semin. Cancer Biol. 14 (2004), 149–154.
6. Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5 (2010), 99–118.
7. Deshmane, S.L., Kremlev, S., Amini, S., Sawaya, B.E., Monocyte chemoattractant protein-1 (MCP-1): an overview. J. Interferon Cytokine Res. 29 (2009), 313–326.
8. Gabrilovich, D.I., Nagaraj, S., Myeloid-derived suppressor cells as regulators of the immune system. Nat. Rev. Immunol. 9 (2009), 162–174.
9. Gabrilovich, D.I., Ostrand-Rosenberg, S., Bronte, V., Coordinated regulation of myeloid cells by tumours. Nat. Rev. Immunol. 12 (2012), 253–268.
10. Hoechst, B., Ormandy, L.A., Ballmaier, M., Lehner, F., Kruger, C., Manns, M.P., Greten, T.F., Korangy, F., A new population of myeloid-derived suppressor cells in hepatocellular carcinoma patients induces CD4(+)CD25(+)Foxp3(+) T cells. Gastroenterology 135 (2008), 234–243.
11. Hoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer, H., Lehner, F., Manns, M.P., Greten, T.F., Korangy, F., Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor. Hepatology 50 (2009), 799–807.
12. Iannello, A., Thompson, T.W., Ardolino, M., Lowe, S.W., Raulet, D.H., p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells. J. Exp. Med. 210 (2013), 2057–2069.
13. Jackson, J.G., Pant, V., Li, Q., Chang, L.L., Quintas-Cardama, A., Garza, D., Tavana, O., Yang, P., Manshouri, T., Li, Y., et al. p53-mediated senescence impairs the apoptotic response to chemotherapy and clinical outcome in breast cancer. Cancer Cell 21 (2012), 793–806.
14. Jurk, D., Wilson, C., Passos, J.F., Oakley, F., Correia-Melo, C., Greaves, L., Saretzki, G., Fox, C., Lawless, C., Anderson, R., et al. Chronic inflammation induces telomere dysfunction and accelerates ageing in mice. Nat. Commun., 2, 2014, 4172.
15. Kang, T.W., Yevsa, T., Woller, N., Hoenicke, L., Wuestefeld, T., Dauch, D., Hohmeyer, A., Gereke, M., Rudalska, R., Potapova, A., et al. Senescence surveillance of pre-malignant hepatocytes limits liver cancer development. Nature 479 (2011), 547–551.
16. Krizhanovsky, V., Yon, M., Dickins, R.A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., Lowe, S.W., Senescence of activated stellate cells limits liver fibrosis. Cell 134 (2008), 657–667.
17. Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.Y., Campisi, J., Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc. Natl. Acad. Sci. USA 98 (2001), 12072–12077.
18. Kuilman, T., Michaloglou, C., Vredeveld, L.C., Douma, S., van Doorn, R., Desmet, C.J., Aarden, L.A., Mooi, W.J., Peeper, D.S., Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell 133 (2008), 1019–1031.
19. Kuilman, T., Michaloglou, C., Mooi, W.J., Peeper, D.S., The essence of senescence. Genes Dev. 24 (2010), 2463–2479.
20. Li, H., Han, Y., Guo, Q., Zhang, M., Cao, X., Cancer-expanded myeloid-derived suppressor cells induce anergy of NK cells through membrane-bound TGF-beta 1. J. Immunol. 182 (2009), 240–249.
21. Li, M., Knight, D.A., A Snyder, L., Smyth, M.J., Stewart, T.J., A role for CCL2 in both tumor progression and immunosurveillance. Oncoimmunology, 2, 2013, e25474.
22. Lujambio, A., Akkari, L., Simon, J., Grace, D., Tschaharganeh, D.F., Bolden, J.E., Zhao, Z., Thapar, V., Joyce, J.A., Krizhanovsky, V., Lowe, S.W., Non-cell-autonomous tumor suppression by p53. Cell 153 (2013), 449–460.
23. Mao, Y., Poschke, I., Wennerberg, E., Pico de Coana, Y., Egyhazi Brage, S., Schultz, I., Hansson, J., Masucci, G., Lundqvist, A., Kiessling, R., Melanoma-educated CD14+ cells acquire a myeloid-derived suppressor cell phenotype through COX-2-dependent mechanisms. Cancer Res. 73 (2013), 3877–3887.
24. Mao, Y., Sarhan, D., Steven, A., Seliger, B., Kiessling, R., Lundqvist, A., Inhibition of tumor-derived prostaglandin-e2 blocks the induction of myeloid-derived suppressor cells and recovers natural killer cell activity. Clin. Cancer Res. 20 (2014), 4096–4106.
25. Mudbhary, R., Hoshida, Y., Chernyavskaya, Y., Jacob, V., Villanueva, A., Fiel, M.I., Chen, X., Kojima, K., Thung, S., Bronson, R.T., et al. UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell 25 (2014), 196–209.
26. Nardella, C., Clohessy, J.G., Alimonti, A., Pandolfi, P.P., Pro-senescence therapy for cancer treatment. Nat. Rev. Cancer 11 (2011), 503–511.
27. Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R.P., Kalinski, P., Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 118 (2011), 5498–5505.
28. Qian, B.Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L.R., Kaiser, E.A., Snyder, L.A., Pollard, J.W., CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 475 (2011), 222–225.
29. Roessler, S., Jia, H.L., Budhu, A., Forgues, M., Ye, Q.H., Lee, J.S., Thorgeirsson, S.S., Sun, Z., Tang, Z.Y., Qin, L.X., Wang, X.W., A unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res. 70 (2010), 10202–10212.
30. Schneider, C., Teufel, A., Yevsa, T., Staib, F., Hohmeyer, A., Walenda, G., Zimmermann, H.W., Vucur, M., Huss, S., Gassler, N., et al. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer. Gut 61 (2012), 1733–1743.
31. Strauss, L., Sangaletti, S., Consonni, F.M., Szebeni, G., Morlacchi, S., Totaro, M.G., Porta, C., Anselmo, A., Tartari, S., Doni, A., et al. RORC1 regulates tumor-promoting “emergency” granulo-monocytopoiesis. Cancer Cell 28 (2015), 253–269.
32. Struthers, M., Pasternak, A., CCR2 antagonists. Curr. Top. Med. Chem. 10 (2010), 1278–1298.
33. Sun, J.C., Lanier, L.L., NK cell development, homeostasis and function: parallels with CD8(+) T cells. Nat. Rev. Immunol. 11 (2011), 645–657.
34. Taketomi, A., Shimada, M., Shirabe, K., Kajiyama, K., Gion, T., Sugimachi, K., Natural killer cell activity in patients with hepatocellular carcinoma: a new prognostic indicator after hepatectomy. Cancer 83 (1998), 58–63.
35. Toso, A., Revandkar, A., Di Mitri, D., Guccini, I., Proietti, M., Sarti, M., Pinton, S., Zhang, J., Kalathur, M., Civenni, G., et al. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity. Cell Rep. 9 (2014), 75–89.
36. Wu, Y., Kuang, D.M., Pan, W.D., Wan, Y.L., Lao, X.M., Wang, D., Li, X.F., Zheng, L., Monocyte/macrophage-elicited natural killer cell dysfunction in hepatocellular carcinoma is mediated by CD48/2B4 interactions. Hepatology 57 (2013), 1107–1116.
37. Xue, W., Zender, L., Miething, C., Dickins, R.A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., Lowe, S.W., Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature 445 (2007), 656–660.
38. Yildiz, G., Arslan-Ergul, A., Bagislar, S., Konu, O., Yuzugullu, H., Gursoy-Yuzugullu, O., Ozturk, N., Ozen, C., Ozdag, H., Erdal, E., et al. Genome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesis. PLoS One, 8, 2013, e64016.
39. Yuzefpolskiy, Y., Baumann, F.M., Kalia, V., Sarkar, S., Early CD8 T-cell memory precursors and terminal effectors exhibit equipotent in vivo degranulation. Cell Mol. Immunol. 12 (2015), 400–408.
40. Zigmond, E., Samia-Grinberg, S., Pasmanik-Chor, M., Brazowski, E., Shibolet, O., Halpern, Z., Varol, C., Infiltrating monocyte-derived macrophages and resident Kupffer cells display different ontogeny and functions in acute liver injury. J. Immunol. 193 (2014), 344–353.